Pearls

Is psychosis toxic to the brain?

Author and Disclosure Information

 

References

Schizophrenia has been described as the “worst disease” to afflict mankind.1 It causes psychosis, which is an abnormal state of mind marked by hyperarousal, overactivation of brain circuits, and emotional distress. An untreated episode of psychosis can result in structural brain damage due to neurotoxicity. Patients who experience psychosis may be affected by inflammatory processes, oxidative and nitrosative reactions, mitochondrial dysfunction, decreased synaptic plasticity and neurogenesis, demyelination, and autoimmune attacks—all of which can contribute to cell necrosis and irreversible neuronal atrophy.2-4

The impacts of untreated psychosis

First-episode psychosis (FEP) can result in a loss of up to 1% of total brain volume and up to 3% of cortical gray matter.4,5 When FEP goes untreated, approximately 10 to 12 cc of brain tissue—basically a tablespoon of cells and myelin—could be permanently damaged.2,6,7 This explains why enlarged ventricles are a common radiologic finding in patients with schizophrenia.2 In such patients, imaging of the brain will show these as hollow, fluid-filled spaces that appear expanded.

Repeated episodes of untreated psychosis could result in progressively lower levels of baseline functioning, and patients may require longer hospitalizations to achieve stabilization and higher doses of medications to achieve remission.4,7 Greater brain volume losses are associated with poorer outcomes.3 Brain volume loss is also detectable in patients with untreated major depressive episodes,8 and recurrent episodes of bipolar I disorder can also result in the loss of gray matter and structural brain damage.9 The progressive decline in cognitive and functional outcomes and eventual development of treatment resistance are likely due to a kindling phenomenon or receptor sensitization.10

Act fast to prevent brain damage

Since it was first identified, schizophrenia has been recognized as a degenerative disease. However, the progression to structural brain damage is not inevitable, and can be arrested with expeditious, decisive treatment. Some agents, such as certain antipsychotic medications10 and omega-3 fatty acids, can be neuroprotective.11 The early use of a long-acting injectable antipsychotic also may help prevent relapse and additional psychotic episodes.5

Psychosis requires expedient and competent intervention to improve outcomes and reduce disease burden. Timely psychiatric treatment can improve not only immediate functioning, but also long-term prognosis. Because untreated psychosis can result in irreversible structural brain damage, clinicians must act swiftly to provide assertive treatment.

Recommended Reading

Top research findings of 2018-2019 for clinical practice
MDedge Psychiatry
Cardiovascular disease risk higher in patients with schizophrenia, metabolic syndrome
MDedge Psychiatry
Early cognitive screening is key for schizophrenia spectrum disorder
MDedge Psychiatry
Cigarette smoking is associated with prefrontal function in patients with schizophrenia
MDedge Psychiatry
TNF-alpha, oxidative stress disturbance may play role in schizophrenia pathophysiology
MDedge Psychiatry
Severe infection tied to substance-induced psychosis, conversion to schizophrenia
MDedge Psychiatry
Transporting the high-risk psychiatric patient: Clinical and legal challenges
MDedge Psychiatry
Second-generation long-acting injectable antipsychotics: A practical guide
MDedge Psychiatry
Coronavirus on the inpatient unit: A new challenge for psychiatry
MDedge Psychiatry
Psychiatric patients and pandemics
MDedge Psychiatry